EGRX

Eagle Pharmaceuticals, Inc.
EGRX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

EGRX was delisted on the 2nd of October, 2024.

Back to rankings

166 hedge funds and large institutions have $574M invested in Eagle Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 70 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
166
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$7.22M
2
+$5.09M
3
+$3.12M
4
Two Sigma Investments
Two Sigma Investments
New York
+$2.49M
5
SG Americas Securities
SG Americas Securities
New York
+$1.73M

Top Sellers

1
-$14.3M
2
-$5.16M
3
-$4.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$4.14M
5
Renaissance Technologies
Renaissance Technologies
New York
-$2.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4.92M
27
$4.76M
28
$4.18M
29
$3.96M
30
$3.82M
31
$3.8M
32
$3.52M
33
$3.5M
34
$3.36M
35
$3.14M
36
$2.92M
37
$2.8M
38
$2.75M
39
$2.4M
40
$2.31M
41
$2.11M
42
$2.08M
43
$1.82M
44
$1.74M
45
$1.67M
46
$1.65M
47
$1.63M
48
$1.6M
49
$1.47M
50
$1.46M
1
2
3 4 5